169 related articles for article (PubMed ID: 24456330)
1. Pathobiological properties of the ubiquitin ligase Nedd4L in melanoma.
Kito Y; Bai J; Goto N; Okubo H; Adachi Y; Nagayama T; Takeuchi T
Int J Exp Pathol; 2014 Feb; 95(1):24-8. PubMed ID: 24456330
[TBL] [Abstract][Full Text] [Related]
2. Nedd4L modulates the transcription of metalloproteinase-1 and -13 genes to increase the invasive activity of gallbladder cancer.
Takeuchi T; Adachi Y; Nagayama T; Furihata M
Int J Exp Pathol; 2011 Apr; 92(2):79-86. PubMed ID: 21039987
[TBL] [Abstract][Full Text] [Related]
3. miR-93 promotes TGF-β-induced epithelial-to-mesenchymal transition through downregulation of NEDD4L in lung cancer cells.
Qu MH; Han C; Srivastava AK; Cui T; Zou N; Gao ZQ; Wang QE
Tumour Biol; 2016 Apr; 37(4):5645-51. PubMed ID: 26581907
[TBL] [Abstract][Full Text] [Related]
4. The Ubiquitin Ligase Nedd4L Regulates the Na/K/2Cl Co-transporter NKCC1/SLC12A2 in the Colon.
Jiang C; Kawabe H; Rotin D
J Biol Chem; 2017 Feb; 292(8):3137-3145. PubMed ID: 28087701
[TBL] [Abstract][Full Text] [Related]
5. NEDD4L regulates convergent extension movements in Xenopus embryos via Disheveled-mediated non-canonical Wnt signaling.
Zhang Y; Ding Y; Chen YG; Tao Q
Dev Biol; 2014 Aug; 392(1):15-25. PubMed ID: 24833518
[TBL] [Abstract][Full Text] [Related]
6. The short isoform of the ubiquitin ligase NEDD4L is a CREB target gene in hepatocytes.
Fu J; Akhmedov D; Berdeaux R
PLoS One; 2013; 8(10):e78522. PubMed ID: 24147136
[TBL] [Abstract][Full Text] [Related]
7. NEDD4L on human chromosome 18q21 has multiple forms of transcripts and is a homologue of the mouse Nedd4-2 gene.
Chen H; Ross CA; Wang N; Huo Y; MacKinnon DF; Potash JB; Simpson SG; McMahon FJ; DePaulo JR; McInnis MG
Eur J Hum Genet; 2001 Dec; 9(12):922-30. PubMed ID: 11840194
[TBL] [Abstract][Full Text] [Related]
8. Nedd4L expression is decreased in ovarian epithelial cancer tissues compared to ovarian non-cancer tissue.
Yang Q; Zhao J; Cui M; Gi S; Wang W; Han X
J Obstet Gynaecol Res; 2015 Dec; 41(12):1959-64. PubMed ID: 26554540
[TBL] [Abstract][Full Text] [Related]
9. DDB2 modulates TGF-β signal transduction in human ovarian cancer cells by downregulating NEDD4L.
Zhao R; Cui T; Han C; Zhang X; He J; Srivastava AK; Yu J; Wani AA; Wang QE
Nucleic Acids Res; 2015 Sep; 43(16):7838-49. PubMed ID: 26130719
[TBL] [Abstract][Full Text] [Related]
10. HECT domain-containing E3 ubiquitin ligase NEDD4L negatively regulates Wnt signaling by targeting dishevelled for proteasomal degradation.
Ding Y; Zhang Y; Xu C; Tao QH; Chen YG
J Biol Chem; 2013 Mar; 288(12):8289-8298. PubMed ID: 23396981
[TBL] [Abstract][Full Text] [Related]
11. Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling.
Gao S; Alarcón C; Sapkota G; Rahman S; Chen PY; Goerner N; Macias MJ; Erdjument-Bromage H; Tempst P; Massagué J
Mol Cell; 2009 Nov; 36(3):457-68. PubMed ID: 19917253
[TBL] [Abstract][Full Text] [Related]
12. JP1 suppresses proliferation and metastasis of melanoma through MEK1/2 mediated NEDD4L-SP1-Integrin αvβ3 signaling.
Cui J; Shu C; Xu J; Chen D; Li J; Ding K; Chen M; Li A; He J; Shu Y; Yang L; Zhang R; Zhou J
Theranostics; 2020; 10(18):8036-8050. PubMed ID: 32724456
[No Abstract] [Full Text] [Related]
13. Decreased expression of NEDD4L contributes to NSCLC progression and metastasis.
Wang X; Duan J; Fu W; Yin Z; Sheng J; Lei Z; Wang H
Biochem Biophys Res Commun; 2019 May; 513(2):398-404. PubMed ID: 30967264
[TBL] [Abstract][Full Text] [Related]
14. p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation.
Terzian T; Torchia EC; Dai D; Robinson SE; Murao K; Stiegmann RA; Gonzalez V; Boyle GM; Powell MB; Pollock PM; Lozano G; Robinson WA; Roop DR; Box NF
Pigment Cell Melanoma Res; 2010 Dec; 23(6):781-94. PubMed ID: 20849464
[TBL] [Abstract][Full Text] [Related]
15. NDFIP allows NEDD4/NEDD4L-induced AQP2 ubiquitination and degradation.
Trimpert C; Wesche D; de Groot T; Pimentel Rodriguez MM; Wong V; van den Berg DTM; Cheval L; Ariza CA; Doucet A; Stagljar I; Deen PMT
PLoS One; 2017; 12(9):e0183774. PubMed ID: 28931009
[TBL] [Abstract][Full Text] [Related]
16. NEDD4L is downregulated in colorectal cancer and inhibits canonical WNT signaling.
Tanksley JP; Chen X; Coffey RJ
PLoS One; 2013; 8(11):e81514. PubMed ID: 24312311
[TBL] [Abstract][Full Text] [Related]
17. Indole-3-carbinol (I3C) analogues are potent small molecule inhibitors of NEDD4-1 ubiquitin ligase activity that disrupt proliferation of human melanoma cells.
Quirit JG; Lavrenov SN; Poindexter K; Xu J; Kyauk C; Durkin KA; Aronchik I; Tomasiak T; Solomatin YA; Preobrazhenskaya MN; Firestone GL
Biochem Pharmacol; 2017 Mar; 127():13-27. PubMed ID: 27979631
[TBL] [Abstract][Full Text] [Related]
18. Deletion of ubiquitin ligase Nedd4l exacerbates ischemic brain damage.
Kim T; Chokkalla AK; Vemuganti R
J Cereb Blood Flow Metab; 2021 May; 41(5):1058-1066. PubMed ID: 32703111
[TBL] [Abstract][Full Text] [Related]
19. NEDD4-2 (NEDD4L): the ubiquitin ligase for multiple membrane proteins.
Goel P; Manning JA; Kumar S
Gene; 2015 Feb; 557(1):1-10. PubMed ID: 25433090
[TBL] [Abstract][Full Text] [Related]
20. Oncogenic role of the E3 ubiquitin ligase NEDD4-1, a PTEN negative regulator, in non-small-cell lung carcinomas.
Amodio N; Scrima M; Palaia L; Salman AN; Quintiero A; Franco R; Botti G; Pirozzi P; Rocco G; De Rosa N; Viglietto G
Am J Pathol; 2010 Nov; 177(5):2622-34. PubMed ID: 20889565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
